Skip to main content
Figure 3 | BMC Medical Research Methodology

Figure 3

From: Using observational data to estimate an upper bound on the reduction in cancer mortality due to periodic screening

Figure 3

Difference per 10,000 deaths between PSE randomized estimate and PSE nonrandomized upper bound estimate (with 95% confidence interval). MCCCS-1 is Minnesota Colorectal Cancer Control Study, ages 50 to 71, annual screens, MCCCS-2 is Minnesota Colorectal Cancer Control Study, ages 50 to 71, bienniel screens, HIP is Health Insurance Program study of annual breast cancer screening, ages 40 to 64, MLP is Mayo Lung Project, ages 51 to 69 with screens every 4 months.

Back to article page

BMC Medical Research Methodology

ISSN: 1471-2288

Contact us